The immune system is one of the most complex and dynamic biological systems in the human body—capable of distinguishing self from non-self, mounting targeted responses to pathogens and tumors, and maintaining immunological memory across a lifetime. Immune profiling services that characterize the cellular and molecular composition of the immune system at high resolution are enabling researchers to understand immunity in ways that were previously out of reach, with implications ranging from vaccine development to cancer immunotherapy and autoimmune disease.
The dimensions of immune profiling
Modern immune profiling spans multiple biological layers. At the cellular level, single-cell RNA sequencing and multi-parameter flow cytometry resolve immune cell populations with granularity that bulk methods cannot achieve—distinguishing not just broad lineages like T cells and B cells, but specific functional subsets, activation states, and transitional populations. At the molecular level, T cell receptor (TCR) and B cell receptor (BCR) sequencing captures the clonotypic diversity of adaptive immune responses, enabling tracking of antigen-specific clones across time, tissues, and treatment conditions.
Single-cell approaches in immune research
Single-cell sequencing has fundamentally changed immune profiling by enabling simultaneous measurement of transcriptome, surface protein expression, and receptor sequence from individual cells. Technologies like CITE-seq pair RNA sequencing with antibody-based protein detection, providing a multi-dimensional view of immune cell identity and state in a single experiment. This resolution is particularly valuable for dissecting immune heterogeneity within tumors, lymphoid tissues, and sites of inflammation—where bulk profiling would obscure the functional diversity that drives biological outcomes.
Immune profiling in oncology
The tumor immune microenvironment is a major determinant of cancer progression and response to immunotherapy. Immune profiling services characterizing the cellular composition, functional state, and clonal dynamics of tumor-infiltrating immune populations are providing critical context for understanding why some patients respond to checkpoint blockade while others do not. Biomarkers derived from immune profiling—including T cell exhaustion signatures, regulatory T cell infiltration, and TCR clonotype diversity—are increasingly being evaluated as predictive and prognostic markers in clinical trials.
Autoimmune and inflammatory disease applications
In autoimmune and inflammatory conditions, immune profiling is revealing the cellular and molecular underpinnings of dysregulated immunity. Characterizing autoreactive T and B cell populations, identifying disease-associated clonotypes, and mapping the transcriptional states of innate and adaptive immune cells in affected tissues are providing new mechanistic insights into conditions ranging from rheumatoid arthritis and lupus to inflammatory bowel disease. These findings are informing the development of more targeted therapeutic strategies aimed at specific immune cell populations or pathways rather than broad immunosuppression.
Vaccine and infectious disease research
Immune profiling services are also central to vaccine research and infectious disease immunology. Characterizing the breadth, depth, and durability of antigen-specific B cell and T cell responses following vaccination or infection informs understanding of protective immunity and guides the design of next-generation vaccine platforms. Single-cell profiling of germinal center reactions and plasmablast responses has provided new insight into how affinity maturation shapes antibody responses—knowledge directly applicable to the development of vaccines against variable pathogens.
Conclusion
Immune profiling services are providing researchers with an unprecedented view of immune system composition, function, and dynamics. By resolving immune biology at single-cell and molecular resolution—across oncology, autoimmunity, infection, and vaccine research—these approaches are generating the mechanistic understanding needed to develop more effective diagnostics, biomarkers, and therapies for immune-mediated diseases.